Kyowa Kirin To Lower Cost Of Medicines For American Patients; U.S. To Defer Section 232 Tariffs

Kyowa Kirin announced a voluntary agreement with the U.S. government to participate in the GENEROUS model, aiming to improve access and lower the cost of medicines for American patients. The release provides no specific financial terms or pricing/cost figures in the excerpt provided. Overall, this is a modestly positive policy/access update with limited near-term impact absent disclosed monetary details.